• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔镜胸膜活检提高 Xpert MTB/RIF 检测胸腔结核的阳性率。

Thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis.

机构信息

Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.

出版信息

Respirology. 2018 Jul;23(7):714-717. doi: 10.1111/resp.13275. Epub 2018 Feb 27.

DOI:10.1111/resp.13275
PMID:29486527
Abstract

BACKGROUND AND OBJECTIVE

Extrapulmonary tuberculosis (EPTB) accounts for ~15% of all TB patients, and TB pleural effusion is the second most common site of EPTB. The diagnosis of pleural TB is challenging due to the pauci-bacillary nature of the disease. Histopathology of thoracoscopically obtained pleural biopsy provides the highest diagnostic yield. The Xpert MTB/RIF assay (Xpert) is a PCR test that can identify both Mycobacterium tuberculosis (MTB) and rifampicin resistance. Currently, there is a lack of clarity regarding the value of Xpert on pleural tissue. We report our experience of using Xpert on thoracoscopic pleural biopsy samples.

METHODS

We retrospectively reviewed the records of patients who underwent thoracoscopy in our institution over a 1-year period. Relevant clinical details; indications; and results of tests on pleural tissue and fluid, including histopathology, mycobacterial cultures and Xpert, were extracted.

RESULTS

Of the 156 patients who underwent thoracoscopy, 73 (47%) had TB, 66 (42%) malignancy and 17 (11%) other conditions. Histopathology was diagnostic in all the 73 TB patients (100%). The yields of the microbiological tests against histopathology on thoracoscopic biopsy sample and pleural fluid were: pleural tissue Xpert 45%, pleural tissue culture 39%, pleural fluid culture 17% and pleural fluid Xpert 14%. Pleural tissue provided higher yields than fluid in both Xpert and culture (P < 0.05). Pleural tissue Xpert provided a higher yield than culture and substantially improved yield compared with closed pleural biopsy as we previously reported.

CONCLUSION

Thoracoscopic pleural biopsy results in increased sensitivity on Xpert testing.

摘要

背景和目的

肺外结核病(EPTB)约占所有结核病患者的 15%,结核性胸腔积液是第二常见的 EPTB 部位。由于疾病的菌量少,胸腔积液结核的诊断具有挑战性。经胸腔镜获取的胸膜活检的组织病理学提供了最高的诊断率。Xpert MTB/RIF assay(Xpert)是一种可以同时识别结核分枝杆菌(MTB)和利福平耐药的 PCR 检测。目前,关于 Xpert 在胸膜组织上的价值尚不清楚。我们报告了使用 Xpert 检测胸腔镜胸膜活检样本的经验。

方法

我们回顾性分析了在我们机构进行胸腔镜检查的患者记录。提取了相关的临床详细信息;适应证;以及胸腔组织和胸腔积液的检测结果,包括组织病理学、分枝杆菌培养和 Xpert。

结果

在 156 例接受胸腔镜检查的患者中,73 例(47%)患有结核病,66 例(42%)患有恶性肿瘤,17 例(11%)患有其他疾病。所有 73 例结核病患者的组织病理学检查均具有诊断意义(100%)。胸腔镜活检标本和胸腔积液的微生物学检测结果与组织病理学检查的符合率分别为:胸膜组织 Xpert 检测 45%,胸膜组织培养 39%,胸腔积液培养 17%,胸腔积液 Xpert 检测 14%。胸膜组织的 Xpert 和培养检测的阳性率均高于胸腔积液(P<0.05)。我们之前的报告表明,与闭式胸膜活检相比,胸膜组织 Xpert 检测的阳性率更高,且显著提高了检测的阳性率。

结论

胸腔镜胸膜活检可提高 Xpert 检测的敏感性。

相似文献

1
Thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis.胸腔镜胸膜活检提高 Xpert MTB/RIF 检测胸腔结核的阳性率。
Respirology. 2018 Jul;23(7):714-717. doi: 10.1111/resp.13275. Epub 2018 Feb 27.
2
Xpert MTB/RIF Ultra enhanced tuberculous pleurisy diagnosis for patients with unexplained exudative pleural effusion who underwent a pleural biopsy via thoracoscopy: A prospective cohort study.Xpert MTB/RIF Ultra 增强型结核性胸膜炎诊断用于经胸腔镜胸膜活检的不明渗出性胸腔积液患者:一项前瞻性队列研究。
Int J Infect Dis. 2021 May;106:370-375. doi: 10.1016/j.ijid.2021.04.011. Epub 2021 Apr 15.
3
Xpert® MTB/RIF in pleural fluid for the diagnosis of tuberculosis.Xpert® MTB/RIF 检测胸腔积液在结核病诊断中的应用。
Int J Tuberc Lung Dis. 2013 Sep;17(9):1217-9. doi: 10.5588/ijtld.13.0178. Epub 2013 Jul 3.
4
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
5
Performance of Xpert® MTB/RIF in diagnosing tuberculous pleuritis using thoracoscopic pleural biopsy.Xpert® MTB/RIF 在经胸腔镜胸膜活组织检查诊断结核性胸膜炎中的表现。
BMC Infect Dis. 2020 Nov 12;20(1):840. doi: 10.1186/s12879-020-05578-3.
6
A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.中国某教学医院应用 Xpert MTB/RIF 检测结核病的回顾性研究。
BMC Infect Dis. 2020 May 24;20(1):362. doi: 10.1186/s12879-020-05004-8.
7
Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting.在艾滋病毒/结核病高流行环境中,评估赛沛Xpert MTB/Rif检测对胸腔积液诊断结核性胸膜炎的效果。
PLoS One. 2014 Jul 22;9(7):e102702. doi: 10.1371/journal.pone.0102702. eCollection 2014.
8
Yield of pleural biopsy in different types of tubercular effusions.不同类型结核性胸腔积液胸膜活检的阳性率。
Indian J Tuberc. 2020 Oct;67(4):523-527. doi: 10.1016/j.ijtb.2020.07.023. Epub 2020 Jul 30.
9
Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.Xpert MTB/RIF检测在福尔马林固定、石蜡包埋组织中诊断结核病的性能。
Int J Mycobacteriol. 2017 Jan-Mar;6(1):87-93. doi: 10.4103/2212-5531.201892.
10
Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples.使用胸腔积液样本的Xpert MTB/RIF检测法在胸膜结核诊断中的性能
J Clin Microbiol. 2015 Nov;53(11):3636-8. doi: 10.1128/JCM.02182-15. Epub 2015 Aug 26.

引用本文的文献

1
Granzyme A as biomarker for diagnosis in tuberculous pleural effusion.颗粒酶A作为结核性胸腔积液诊断的生物标志物。
JCI Insight. 2024 Dec 6;9(23):e185307. doi: 10.1172/jci.insight.185307.
2
Microbiological confirmation of tuberculous pleurisy with medical thoracoscopy: targeted pleural washing and pleural biopsy.经内科胸腔镜对结核性胸膜炎进行微生物学确诊:靶向胸膜冲洗和胸膜活检。
J Thorac Dis. 2024 Aug 31;16(8):4904-4913. doi: 10.21037/jtd-24-143. Epub 2024 Aug 5.
3
Prospective Evaluation of Safety and Diagnostic Efficacy of Medical Thoracoscopy in Undiagnosed Exudative Pleural Effusion: Experience From a Tuberculosis High-Burden Country.
未确诊渗出性胸腔积液中内科胸腔镜检查安全性及诊断效能的前瞻性评估:来自结核病高负担国家的经验
Cureus. 2024 Jun 30;16(6):e63517. doi: 10.7759/cureus.63517. eCollection 2024 Jun.
4
Efficacy of Xpert in tuberculosis diagnosis based on various specimens: a systematic review and meta-analysis.基于各种标本的 Xpert 在结核病诊断中的疗效:系统评价和荟萃分析。
Front Cell Infect Microbiol. 2023 May 2;13:1149741. doi: 10.3389/fcimb.2023.1149741. eCollection 2023.
5
Comparison of Performances of GeneXpert MTB/RIF, Bactec MGIT 960, and Bactec Myco/F Systems in Detecting Mycobacterium tuberculosis in Biopsy Tissues: a Retrospective Study.GeneXpert MTB/RIF、Bactec MGIT 960 和 Bactec Myco/F 系统检测活检组织中结核分枝杆菌的性能比较:一项回顾性研究。
Microbiol Spectr. 2023 Jun 15;11(3):e0141422. doi: 10.1128/spectrum.01414-22. Epub 2023 May 8.
6
The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis.支气管内超声联合 Xpert MTB/RIF Ultra 检测在菌阴肺结核中的诊断性能。
BMC Infect Dis. 2023 Feb 22;23(1):107. doi: 10.1186/s12879-023-08073-7.
7
Use of Pleural Fluid Digital PCR Analysis to Improve the Diagnosis of Pleural Tuberculosis.胸腔积液数字 PCR 分析在提高胸腔结核诊断中的应用。
Microbiol Spectr. 2022 Dec 21;10(6):e0163222. doi: 10.1128/spectrum.01632-22. Epub 2022 Oct 20.
8
The Clinical Experience of Mycobacterial Culture Yield of Pleural Tissue by Pleuroscopic Pleural Biopsy among Tuberculous Pleurisy Patients.胸腔镜胸膜活检术对结核性胸膜炎患者胸膜组织分枝杆菌培养阳性率的临床经验。
Medicina (Kaunas). 2022 Sep 15;58(9):1280. doi: 10.3390/medicina58091280.
9
Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion.白细胞介素 32 作为结核性胸腔积液诊断的潜在标志物。
Microbiol Spectr. 2022 Aug 31;10(4):e0255321. doi: 10.1128/spectrum.02553-21. Epub 2022 Jul 26.
10
Performance of TB-LAMP in the Diagnosis of Tuberculous Empyema Using Samples Obtained From Pleural Decortication.利用胸膜剥脱术获取的样本,结核环介导等温扩增技术在结核性脓胸诊断中的性能
Front Med (Lausanne). 2022 Jun 29;9:879772. doi: 10.3389/fmed.2022.879772. eCollection 2022.